Doctors’ Knowledge and Practices Regarding Chronic Kidney Disease at a Tertiary Care Hospital by Mahmud, Mahvesh et al.
InternatIonal archIves of MedIcIne 
sectIon: nephrology
ISSN: 1755-7682
International 
Medical Society 
http://imedicalsociety.org
1
2016
Vol. 9 No. 88
doi: 10.3823/1959
© Under License of Creative Commons Attribution 3.0 License This article is available at: www.intarchmed.com and www.medbrary.com 
Abstract
Background: The complications of chronic kidney disease (CKD) 
significantly contribute to morbidity and mortality, therefore clinical 
practice guidelines have been developed to facilitate early detection 
and treatment. However, given the high prevalence of CKD, many 
patients with early CKD are seen by non-nephrologists, who need to 
be aware of CKD complications, screening methods and treatments 
goals in order to initiate timely therapy and referral.
Methods: This was a cross-sectional study conducted at three cam-
puses of the Ziauddin University Hospital, Karachi, Pakistan in 2016. A 
questionnaire based survey was conducted to assess the knowledge 
and practices of doctors from various specialties regarding CKD.
Results: We performed a questionnaire based survey to assess 
knowledge and practice patterns in CKD care among 156 doctors. 
There were 63 male and 50 female respondents. There were 24 at-
tending doctors, 73 post-graduate trainees and 25 house-officers. Our 
data showed that although CKD risk factors are generally recognized, 
there is a paucity of knowledge regarding CKD management guideli-
nes and staging of CKD. There is an awareness regarding timely refe-
rral to nephrology, but many would still not refer at the appropriate 
stage. Many also do not use standard equations to calculate Glomeru-
lar Filtration rate (GFR) and Creatinine Clearance]. Most do screen for 
diabetic nephropathy, know about ACE-I/ARBs and provide dietary 
counseling to CKD patients. The majority do not read medical journals 
to keep their knowledge up-to-date. Junior doctors (post-graduate 
trainees and house-officers) fared better than attending doctors in 
the knowledge and practice parameters.
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Introduction
Chronic kidney disease (CKD) is a common and 
growing problem worldwide. It is in fact, a worldwi-
de epidemic health problem of increasing prevalen-
ce and expenditure [1]. It is a major health problem 
globally, casting an enormous burden on healthcare 
systems, is a source of psychological distress, and is 
associated with cardiovascular diseases, resulting in 
substantial morbidity and mortality [2]. According 
to the Global Burden of Disease Study, CKD was 
ranked 18th in the list of causes of total number of 
global deaths in 2010 [3]. Approximately 12.5% of 
adults in Pakistan show some evidence of kidney 
damage and/or reduced kidney function [4]. Iden-
tification of CKD requires recognition of individual 
risk and appropriate laboratory testing [serum crea-
tinine and/or urinary protein] [5], since symptoms 
generally do not manifest in the earlier stages of 
CKD. 
The worldwide rise in the prevalence of CKD de-
mands changes in the global approach towards the 
prevention of CKD, mainly by detecting the risk fac-
tors [6]. Hypertension and diabetes mellitus are the 
leading important risk factors for CKD in developing 
countries [7]. Many studies have confirmed this as-
sociation - these two diseases share risk factors such 
as smoking and obesity, and promote vascular alte-
rations that increase the risk for developing kidney 
impairment [8]. With the aging of the population 
and the increasing incidence of obesity, hyperten-
sion and diabetes, the number of individuals at risk 
for CKD will continue to increase [9]. In 2003, the 
American Heart Association released a statement 
that CKD is a major risk factor for coronary disease 
[10, 11]. Two later studies demonstrated that the 
risk of death and cardiovascular events in people 
with coronary artery disease are directly related to 
the degree of renal dysfunction [12, 13]. The high 
prevalence of CKD in the population in Pakistan is 
not unexpected since the incidence of hypertension 
and diabetes in Pakistan is one of the highest in the 
world [14, 15].
Earlier-stage CKD can also lead to several compli-
cations, such as anemia and bone mineral metabo-
lism disorders, as well as poor outcomes, including 
cardiovascular events, morbidity, and mortality [16], 
in addition to progression to end-stage renal disea-
se (ESRD), requiring dialysis or transplant for sur-
vival. Despite these known adverse consequences 
of CKD, the majority of persons with the disease, 
especially prior to ESRD, remain unaware of their 
disease [17-19]. Awareness of CKD remains unac-
ceptably low, despite recent attempts to increase 
awareness through dissemination of clinical practice 
guidelines and recommendations for patients with 
CKD or its risk factors to providers [20-22], including 
community awareness events such as World Kidney 
Day [23, 24]. Earlier recognition of CKD can slow 
the progression of CKD, prevent complications, and 
reduce cardiovascular-related outcomes; additiona-
lly, early referral to a nephrologist has been shown 
to improve outcomes for those who progress to 
end-stage renal disease [27-30]. It has been obser-
ved that physicians other than nephrologists are less 
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Conclusion: Our survey shows that there is a requirement for 
continuing education and awareness among doctors regarding CKD 
and its management guidelines, as well as timely referral to a ne-
phrologist. Facing a growing CKD incidence, doctors can have an 
impact on preventing its progression and associated complications 
with increased familiarity of local guidelines. 
InternatIonal archIves of MedIcIne 
sectIon: nephrology
ISSN: 1755-7682
2016
Vol. 9 No. 88
doi: 10.3823/1959
© Under License of Creative Commons Attribution 3.0 License 3
likely to recognize CKD and differ in their clinical 
evaluation of CKD [31]. In a significant number of 
cases, CKD patients are referred to nephrologists 
much later than it would deem appropriate [32]. 
Late evaluation of CKD patients by nephrologists, 
especially those presenting in Stage 5 CKD, is asso-
ciated with suboptimal pre-dialysis care and increa-
sed mortality [33-35]. This is especially pertinent to 
developing countries, where support for renal repla-
cement therapy is constrained for the vast majority 
of ESRD patients by cost and lack of technological 
advancements [36].
Recent studies across Pakistan have shown a 
general lack of awareness among doctors regar-
ding chronic kidney disease. One study from Laho-
re showed that the majority of doctors have poor 
to average knowledge about kidney disease; most 
think that nephrology services are inadequate in their 
hospitals and the subject must be taught before 
graduation from medical school [37]. A study from 
Karachi identified specific gaps in the knowledge 
and approach of general practitioners (GPs) regar-
ding the diagnosis and management of CKD… it 
highlighted the need for educational efforts to in-
crease awareness of clinical practice guidelines and 
recommendations for patients with CKD, in order 
to improve management and clinical outcomes of 
this population of patients [38]. Another study from 
Islamabad showed a need for continuing education 
and awareness among physicians regarding CKD 
management, and the benefits of timely referral 
to a nephrologist [31]. According to a 2006 study, 
there were only about 80 formally trained nephro-
logists in Pakistan for a population of about 160 
million (while the USA had more than 5000 nephro-
logists for a population of 300 million) [39], and the 
situation is not much different ten years later. Until 
the public health services in Pakistan are develo-
ped further and the referral system to nephrologists 
is improved, doctors other than nephrologists will 
continue to see and manage patients with CKD, 
and it is imperative that they should be aware of 
the guidelines regarding the detection, monitoring 
and treatment of CKD.
A Knowledge, Attitude and Practices (KAP) sur-
vey is a quantitative method [predefined questions 
formatted in standardized questionnaires] that pro-
vides access to quantitative and qualitative infor-
mation. KAP surveys reveal misconceptions or mi-
sunderstandings that may represent obstacles to 
the activities that we would like to implement and 
potential barriers to behavior change [40]. In certain 
situations, extensive training provides ample infor-
mation, but there is still no implementation due to 
a lack of conviction about the importance of the 
subject or the belief that this information pertains 
to a different population and cannot be practiced 
in this setting. We therefore aimed to implement a 
“Knowledge and Practice” study for chronic kidney 
disease to identify areas for improvement, in order 
to develop an intervention strategy that reflects 
specific local circumstances and the cultural factors 
that influence them; and to plan educational and 
training activities that are suited to the respective 
population involved. 
Materials and Methods
We conducted a cross-sectional study of doctors to 
assess their awareness and approach towards CKD 
diagnosis and management at the three campuses 
of the Ziauddin Hospital, Karachi (a tertiary care 
hospital) from Jan-Mar 2016.
Survey instrument
We reviewed the Kidney Disease Outcomes and 
Quality Initiatives (KDOQI) commentary on the 2012 
KDIGO clinical practice guidelines for the evaluation 
and management of CKD [22] and identified the-
mes relevant to doctors providing pre-dialysis CKD 
care and referring patients to nephrologists. In the 
absence of a validated questionnaire to meet the 
objectives of our study, we designed a question-
naire to meet local needs. The level of difficulty of 
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the questions was appropriate for doctors who had 
completed their “house-job”, regardless of which 
clinical sub-specialty they were now pursuing. The 
“house-job” in Pakistan is one year of manda-
tory clinical training after graduation from medical 
school in Pakistan, in which the “house-officers” 
[HOs] rotate through the Departments of Medicine 
and Surgery and gain comprehensive clinical expe-
rience. The post graduate training is a four year long 
training in different specialties after completion of 
the house-job. The survey instrument was piloted 
and modified based on feedback. The questionnai-
re was anonymous with no demands for personal 
information. Doctors’ participation was voluntary 
after informed consent
Data was collected on a structured questionnaire 
containing questions on the following basic themes: 
•	 Academic position: data was collected on the 
academic position of the doctors, as well as 
information on the number of years they had 
been in practice. For post-graduate trainees 
(PGs), the year of training was ascertained. 
•	 Knowledge of CKD, including use of formulae 
for estimated (EGFR) to stage CKD, awareness 
of the stages of CKD and of the National Kid-
ney Foundation (NKF) KDOQI guidelines for 
managing CKD, knowledge of “age-related 
decline in GFR”, risk factors for, and compli-
cations of CKD. It also included questions on 
timing of referral to nephrologists, measu-
rement of urine protein in CKD evaluation, 
monitoring of anemia and bone-mineral pa-
rameters in patients with CKD.
•	 Practice questions including routine calcula-
tion of eGFR for CKD evaluation, dosing of 
medications according to creatinine clearan-
ce, screening for diabetic kidney disease, ma-
nagement of hypertension in CKD including 
blood pressure goals, provision of dietary 
counseling to patients with CKD, the need for 
more education on the subject, and sources 
of information about CKD.
Data Collection Methodology
The subjects were asked to fill out the question-
naires at their workplace in front of the authors 
conducting the survey, and the filled forms were 
returned within ten to twenty minutes. A repeat 
visit was conducted after two days to include those 
subjects who could not be contacted during the 
first visit. Overall, 122 doctors out of the 196 enlis-
ted could be surveyed. 
Study Participants
The sample size was estimated to be 96 and con-
venience sampling was the method employed. The 
questionnaires were distributed to doctors from 
the Departments of Medicine, Family Medicine, 
Gynaecology, Dermatology, Psychiatry, Surgery, 
Ophthalmology and Otolaryngology, as these spe-
cialties are the referral base to the nephrologists 
at the hospital. 
Inclusion/Exclusion Criteria
We excluded doctors who had not yet started their 
house-job. 
Statistical analysis
All statistical analyses were conducted using the 
Statistical package for social science SPSS version 
21. A descriptive analysis was carried out for de-
mographic characteristics and results, and presen-
ted as mean ± standard deviation. Frequencies and 
percentages were calculated for gender, position 
of work, and postgraduate qualifications. The data 
were sub-analyzed using the Chi square test for di-
fferences in knowledge among doctors according 
to their year of training, their academic positions 
and specialties. 
Results
The questionnaires were distributed to 156 doctors 
(keeping in mind wastage and non-response), out 
of which 122 completed the survey. There were 63 
male and 59 female respondents. There were 24 
InternatIonal archIves of MedIcIne 
sectIon: nephrology
ISSN: 1755-7682
2016
Vol. 9 No. 88
doi: 10.3823/1959
© Under License of Creative Commons Attribution 3.0 License 5
attending doctors, 25 house-officers and 73 were 
post-graduate trainees. Figure 1 shows the acade-
mic positions of the consultants who took part in 
the survey.
Figure 2 shows the subspecialty break-up for the 
respondents, figure 3 shows the number of years all 
the doctors had been in practice, and Table 1 enlists 
the year of training for the post-graduate trainees. 
Table 2 is a detailed break-up of the knowledge 
parameters in the questionnaire. The majority of res-
Figure 3:  years of practice 1: 0-5 years, 2: 5-10 
years, 3: 10-20 years, 4: >20 years.
Figure 1:  Academic positions of attending doctors 
(Consultants refers to attending doctors 
who do not have faculty positions, se-
nior registrars are attending doctors who 
have just completed their postgraduate 
degree. Assistant professors, associate 
professors and professors are higher up 
in the academic hierarchy in that order). 
AssocProf: Associate Professor.
Figure 2:  Sub-specialties of the respondents.
Table 1.  year of training of post-graduate trainees
Years n=73
1 20
2 33
3 9
4 11
Table 2. Knowledge parameters by position.
Questions
House-Officer Post-graduate trainee Attending Doctor 
N N N
25 % 73 % 24 %
What is the best way to stage CKD? (eGFR) 18 72.0 62 84.9 15 62.5
How many stages of CKD are you aware of? 10 40.0 52 71.2 11 45.8
Are you aware of standard guidelines for CKD 
management?
0 0.0 18 24.7 9 37.5
Which is the most commonly used formula for GFR 
estimation for staging CKD?
2 8.0 10 13.7 5 20.8
Are you aware of age-related decline in GFR? 20 80 51 69.9 19 79.2
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pondents identified eGFR as the best way of staging 
CKD. The majority of post-graduate (PG) trainees 
were aware of the five stages of CKD, but this did 
not hold true for attending doctors and consultants. 
The majority of doctors were not aware of standard 
guidelines for CKD management, neither were they 
aware of the formula (MDRD) used for CKD staging. 
A vast majority was aware of “age-related decline 
in GFR”, and they could correctly identify diabetes 
mellitus (DM), hypertension, renal stone disease and 
chronic glomerulonephritis as risk factors for chronic 
kidney disease. A significant number correctly iden-
tified the complications of CKD. Most also knew 
that late referral to nephrologists increases mortality 
and morbidity among CKD patients. The goal BP for 
CKD was correctly identified by 63% of PGs and 
54% of attending doctors, but only 32% of house-
officers [HOs]. A majority of the respondents knew 
that screening for diabetic nephropathy should be-
gin with the diagnosis of diabetes mellitus (DM).
Table 3 is a detailed break-up of the answers for 
the practice parameters of the questionnaire. A ma-
jority of doctors did refer patients with CKD Stage 
3 and below to nephrology, and they also routinely 
measured urine protein, and monitored anemia and 
bone markers in patients with CKD. However, it was 
the majority of the PG trainee group only who rou-
tinely use standard equations to calculate GFR in 
CKD patients, and also used creatinine clearance to 
adjust medication doses. The majority of doctors 
correctly identified ACE/ARBs as the anti-hyperten-
sives of choice for CKD patients. An overwhelming 
number refer to textbooks for information/updates 
on CKD as compared to journals, seminars and on-
line resources. The majority of doctors also provided 
dietary counselling to CKD patients and routinely 
measured urinary microalbumin to screen for dia-
betic nephropathy.
Table 4 is a post-hoc (Tukey) test comparing all 
the parameters between the attending doctors as 
per their position. The senior registrars and assistant 
professors had more correct answers [indicating su-
perior knowledge/practice] as compared with asso-
ciate professors, professors and consultants.
Questions
House-Officer Post-graduate trainee Attending Doctor 
N N N
25 % 73 % 24 %
Are you aware that the following are risk factors for CKD?
Diabetes Mellitus 25 100.0 71 97.3 22 91.7
Hypertension 24 96.0 71 97.3 22 91.7
Renal stone disease 18 72.0 60 82.2 19 79.2
Chronic glomerulonephritis 23 92.0 66 90.4 24 100.0
Are you aware that the 
following are complications 
of CKD?
Anemia 21 84.0 69 94.5 24 100
Cardiovascular disease 20 80.0 60 82.2 16 66.7
Bone disease 22 88.0 61 83.6 20 83.3
Does late referral to a nephrologist cause high morbidity 
and mortality?
21 84 71 97.3 21 87.5
What is the goal BP for CKD patients? 8 32 46 63 13 54.2
After how many years of diagnosis of DM Type 2 should 
screening for DM start?
13 52 39 53.4 16 66.7
eGFR: estimated Glomerular Filtration Rate. CrCl: Creatinine Clearance. DM: Diabetes Mellitus
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Table 3.  Practice parameters for the respondents. 
Questions
House-Officer 
Post-graduate 
trainee 
Attending Doctor 
N N N
25 % 73 % 24 %
Do you refer patients with CKD stages 3-5 to a nephrologist? 14 56 57 78.1 18 75
Do you routinely measure urine protein in CKD patients 24 96 67 91.8 23 95.8
Do you monitor anemia and iron deficiency in CKD patients? 22 88 69 94.5 22 91.7
Do you monitor calcium, phosphorus and PTH levels in CKD 
patients?
22 88 66 90.4 17 70.8
Do you use standard equations to calculate eGFR in CKD 
patients?
11 44 45 61.6 10 41.7
Do you use creatinine clearance to adjust medication doses 
in CKD patients? 11 44 53 72.6 13 54.2
Which antihypertensive do you prefer for CKD patients? 
(Answered ACE-I/ARB)
19 76 53 72.6 16 66.7
What is/are your primary 
source of 
information/updates 
on CKD?
Medical journals 11 44 37 50.7 13 54.2
CME seminars 10 40 42 57.5 14 58.3
Online articles 15 60 43 58.9 16 66.7
Textbooks 22 88 65 89 18 75
Do you routinely provide dietary counselling to CKD patients? 14 56 49 67.1 17 70.8
Do you routinely measure urinary microalbumin to screen for 
diabetic nephropathy 
14 56 49 67.1 16 66.7
eGFR: estimated glomerular filtration rate. PTH: Parathyroid Hormone. CME: Continuing Medical Education
Table 4.  Post-hoc (Tukey) test for comparison by position of the attending doctors. Tukey HSD-contrasts
Multiple Comparisons
(I) position (J) position
Mean 
Difference (I-J)
Std. 
Error
Sig.
95% Confidence Interval
Lower Bound Upper Bound
Consultant
professor/AssocProf 12.53968 7.14901 .324 -7.4699 32.5493
assistant professor -16.34921 8.86725 .283 -41.1681 8.4697
Sr. registrar -12.73810 6.65044 .253 -31.3522 5.8761
Professor/Assoc 
Prof
consultant -12.53968 7.14901 .324 -32.5493 7.4699
assistant professor -28.88889* 9.08623 .022 -54.3207 -3.4571
Sr. registrar -25.27778* 6.93972 .008 -44.7016 -5.8539
Assistant 
Professor
consultant 16.34921 8.86725 .283 -8.4697 41.1681
professor/AssocProf 28.88889* 9.08623 .022 3.4571 54.3207
Sr. registrar 3.61111 8.69940 .975 -20.7380 27.9602
Sr. registrar
consultant 12.73810 6.65044 .253 -5.8761 31.3522
professor/AssocProf 25.27778* 6.93972 .008 5.8539 44.7016
assistant professor -3.61111 8.69940 .975 -27.9602 20.7380
Dependent Variable: perc. Tukey HSD. *: The mean difference is significant at the 0.05 level.
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Table 5 is a post-hoc (Tukey) test comparing all 
the parameters between all the doctors as per the 
number of years they had been in practice - with 
increasing number of years of practice, the CKD 
knowledge and practice parameters showed a sig-
nificant decline.
Table 6 is the ANOVA test of regression between 
HOs and PG trainees, showing that PG trainees fa-
Table 5. Post-hoc (Tukey) test for comparison by years of practice of all doctors.
Multiple Comparisons
(I) year of 
practice
(J) year of 
practice
Mean 
Difference (I-J)
Std. Error Sig.
95% Confidence Interval
Lower Bound Upper Bound
0-5 yrs
5-10 yrs 2.91667 5.24713 .945 -11.0187 16.8520
10-20 yrs 11.11111 8.07848 .520 -10.3438 32.5660
more then 20 yrs 18.09524* 5.54674 .010 3.3642 32.8263
5-10 yrs
0-5 yrs -2.91667 5.24713 .945 -16.8520 11.0187
10-20 yrs 8.19444 9.11070 .805 -16.0018 32.3907
more then 20 yrs 15.17857 6.96486 .143 -3.3188 33.6759
10-20 yrs
0-5 yrs -11.11111 8.07848 .520 -32.5660 10.3438
5-10 yrs -8.19444 9.11070 .805 -32.3907 16.0018
more then 20 yrs 6.98413 9.28649 .875 -17.6790 31.6472
more than 20 
yrs
0-5 yrs -18.09524* 5.54674 .010 -32.8263 -3.3642
5-10 yrs -15.17857 6.96486 .143 -33.6759 3.3188
10-20 yrs -6.98413 9.28649 .875 -31.6472 17.6790
Dependent Variable: perc. Tukey HSD. *: The mean difference is significant at the 0.05 level.
Table 7. Spearman’s rho, a test for correlation.
Correlations
perc year of practice
year of 
training in PG
Spearman's rho
percentage
Correlation Coefficient 1.000 -.377** .310**
Sig. (2-tailed) . .005 .008
N 125 55 73
year of practice
Correlation Coefficient -.377** 1.000 .
Sig. (2-tailed) .005 . .
N 55 55 22
year of training 
in PG
Correlation Coefficient .310** . 1.000
Sig. (2-tailed) .008 . .
N 73 22 73
**: Correlation is significant at the 0.01 level (2-tailed).
Table 6. Regression HO/PG.
ANOVAa
Model Sum of Squares df Mean Square F Sig.
1
Regression 1164.243 1 1164.243 7.332 .008b
Residual 15243.580 96 158.787
Total 16407.823 97
a: Dependent Variable: perc. b: Predictors: (Constant), HO or PG?
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red better than their juniors in the knowledge and 
practice parameters for CKD management.
Table 7 details the Spearman's Rho, a test for 
ordinal variables, to see whether the mentioned va-
riables are correlated. It checks if an ordinal variable 
(years of practice, years of PG training) is correlated 
with a continuous variable (percentage in this case). 
The p-values are significant and it shows that as the 
years of practice increased the percentage correct 
score decreased, while as the years of training as 
PGs increased, the percentage correct score increa-
sed within that sub-group.
Discussion
The results of our survey highlight the areas that 
need to be worked upon in order to improve the 
quality of care for patients with CKD. In Pakistan, 
patients suffering from CKD are mainly under care 
of internists and general practitioners until they 
reach advanced kidney failure when they are refe-
rred to a nephrologist [38]. The majority of doctors 
were aware of eGFR being the best way to stage 
kidney disease as compared to serum urea or crea-
tinine levels. However, most attending doctors and 
house-officers were not aware that there are five 
stages of CKD, and only a small minority of all could 
correctly identify the MDRD equation used for eGFR 
estimation for CKD staging. Most were not aware 
of standard guidelines used for the management of 
CKD. Only 44% of HOs, 61.6% of PGs and 41.7% 
of attending doctors actually used standard equa-
tions to calculate eGFR in CKD patients, and 44% 
of HOs, 72.6% of PGs, and 54.2% of attending 
doctors actually used the Creatinine Clearance to 
adjust medication doses in CKD patients.
Traditionally, physicians have been relying on 
measurement of serum creatinine alone for kidney 
disease detection and management. The KDOQI 
guidelines recommend that the serum creatini-
ne alone is not an accurate index of the level of 
GFR and that the level of GFR should be estimated 
from prediction equations that take into account 
the serum creatinine concentration and some or all 
of the following variables: age, gender, race and 
body size [41]. Incorporation of these guidelines into 
clinical practice facilitates early detection of CKD by 
primary care providers, identification and manage-
ment of its complications, and also promotes timely 
referral of patients to nephrology services [38]. A 
UNyNET study on ten primary care providers re-
vealed that only one used eGFR, while the rest re-
lied on blood urea, serum creatinine or urinalysis 
alone for diagnosing CKD [42]. In another study at 
a tertiary care hospital, 78% of the respondents 
were aware of eGFR being a better tool to assess 
kidney disease compared to the serum creatinine 
alone, but 48% either did not know when to re-
fer based on eGFR, or still referred on the basis 
of serum creatinine alone [31]. However, a study 
on general practitioners (GPs) in Karachi showed 
that 78% of them would rely on serum creatinine 
for detection of kidney disease [38]. Evidence has 
shown that eGFR measurement in Pakistan by the 
MDRD equation or calculating the creatinine clea-
rance using the Cockcroft Gault equation is a bet-
ter predictor of reduced GFR than serum creatinine 
alone [43], and using serum creatinine alone may 
result in significant under-recognition of CKD as the 
level may still be within normal range even when 
the kidney function is impaired significantly. 
A proper understanding of the KDOQI defini-
tion of CKD is required to be able to make the 
diagnosis of CKD [44]. Rates about awareness of 
KDOQI guidelines reported from other developing 
countries worldwide are low, with 38.8% of non-
nephrology specialists in Nigeria being aware of the 
guidelines [45]. Low CKD awareness implies that 
these patients are not properly managed to delay 
the progression to ESRD [27]. Timely medical inter-
vention which can slow progression of CKD and 
prevent ESRD has been advocate, since the cost of 
ESRD programmes is prohibitive, and the quality of 
life of patients on dialysis is poor [45]. One way of 
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raising physicians’ awareness on staging CKD is to 
recommend that laboratories should systematically 
calculate and even stage the eGFR based on the 
serum creatinine results [46]. Such a strategy has 
been shown to greatly increase the number of re-
ferrals to nephrologists [47, 48].
The majority of respondents in our study knew 
about “age-related decline” in GFR which is a natu-
ral process due to a diminution of nephrons in the 
body with aging. The majority recognized diabe-
tes mellitus, hypertension, renal stone disease and 
chronic glomerulonephritis as being risk factors for 
CKD. This was similar to results noted in a study in 
Cameroon [46], as well as in a web-based survey in 
the US [49]. Several studies have shown an increa-
sed risk for CKD among individuals with diabetes, 
hypertension, autoimmune diseases, urinary tract 
infections, stone diseases, and older age, among 
others [50]. Physicians involved in the care of CKD 
patients should pay attention to a wide range of 
disorders that may develop as a result of loss of 
renal function; it is important to recognize all the 
complications of CKD in order to reduce disease-
related morbidity and mortality [38]. The potential 
complications of CKD were identified by a majority 
of the respondents, but fewer attending doctors 
(66.7%) identified cardiovascular disease as a com-
plication of CKD. The most commonly identified 
complication was anemia, similar to other studies 
[38, 45, 46, 49]. 
In our study, 84% of house-officers, 97.3% of PG 
trainees and 87.5% of attending doctors believed 
that late referral [when patient becomes symptoma-
tic of uremia] to a nephrologist causes high mor-
tality and morbidity. However, only 56% of house-
officers, 78% of PGs and 75% of attending doctors 
would refer patients with a creatinine of 3 or above 
to a nephrologist. Several studies have shown that 
late referral to nephrologists is usually associated 
with adverse outcomes [51-53]. The KDOQI guide-
lines recommend that patients with CKD should be 
referred to a nephrologist when eGFR is less than 60 
ml/min [50]. The potential benefits of early referral 
include slowing CKD progression with timed inter-
ventions, informed selection of dialysis modality and 
non-emergent initiation of dialysis, less frequent and 
shorter hospital stays, lower cost, improved survival 
and likelihood of a pre-emptive transplant [38]. A 
study from the US showed that approximately 25-
50% of patients starting chronic renal replacement 
therapy require dialysis within one month of their 
first nephrology visit [54]. In a Pakistan study, 84% 
of physicians knew that late nephrology referral 
translates into higher morbidity and mortality, but 
48% were unaware as to when to refer the patient 
to a nephrologist based on eGFR [31]. In the Nigeria 
study, very few respondents knew about the crite-
ria for referring CKD patients to nephrology [45]. 
In order to initiate timely referral of CKD patients, 
primary providers need to be aware of risk factors 
for CKD and comorbidities associated with CKD, as 
well as clinical practice guidelines describing opti-
mal CKD care, such as the KDOQI guidelines [50], 
the recommendations from the American Diabetes 
Association (ADA) [21], or the clinical practice guide-
lines developed by the Renal Physicians Association 
(RPA) [55].
There is substantial evidence suggesting the effi-
cacy of Angiotensin Converting Enzyme (ACE) Inhi-
bitors and Angiotensin Receptor Blockers (ARBs) in 
decreasing albuminuria, and delaying the progres-
sion from microalbuminuria to macroalbuminuria 
in patients with proteinuria and CKD [56, 57]. The 
KDOQI guidelines recommend a target blood pres-
sure [BP] of less than 130/80mmHg in patients with 
CKD, and the preferred choice of antihypertensive 
for both diabetic and non-diabetic kidney disease 
are ACE Inhibitors and ARBs [22]. In our study only 
54% of attendings and 32% of house-officers could 
correctly identify the goal BP for CKD, and the num-
ber among PG trainees was higher [63%]. However, 
the majority did choose ACE Inhibitors and ARBs as 
the class of antihypertensives they used in patients 
with CKD. For the 25% of doctors who did not 
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choose this class of drugs, it may be necessary to 
disseminate information about the usefulness of a 
given intervention, and also give hand-on informa-
tion about monitoring, prevention, and treatment 
of potential complications [49]. Data supporting the 
use of ACE Inhibitors and ARBs show that these 
agents are not only beneficial in patients with an 
abnormal serum creatinine, but also safe, as long 
as patients are carefully monitored and counseled 
[58, 59].
Regarding diabetes, the American Diabetes As-
sociation and the KDOQI work-group recommend 
that patients with diabetes should be screened an-
nually for diabetic kidney disease [60]. It is especia-
lly important that clinicians are well-versed in the 
management of diabetes and its attendant compli-
cations, as diabetes is the leading cause of kidney 
failure world-wide, and its prevalence is high in the 
South Asian populations, and is expected to increa-
se 2-fold till 2030 [57]. Initial screening for diabe-
tes with a urine microalbumin should commence 
5 years after the diagnosis of type 1 diabetes, and 
at the time of diagnosis of type 2 diabetes. In our 
study, about half of the HOs and PGs, and 66.7% of 
attendings knew that screening for diabetic nephro-
pathy begins at diagnosis, and 56% of HOs, 67% of 
PGs and 66.7% of HOs routinely measured urinary 
microalbumin to screen for diabetic nephropathy. 
In another study on GPs in Pakistan, the majority 
were aware of when to start screening for diabetic 
nephropathy [38], and in the US study on trainees, 
70% elected to screen for microalbuminuria [49]. 
As the vast majority of diabetic CKD patients are 
under care of GPs and internal medicine doctors, it 
needs to be ensured that emphasis is placed on the 
teaching and hands-on implementation of clinical 
practice guidelines in order to improve the care of 
diabetic CKD patients.
Regarding practice parameters for CKD, the vast 
majority did admit to routinely measuring urinary 
protein and monitoring anemia parameters in CKD 
patients, but the number fell among the attending 
doctors to 70.8% regarding monitoring bone para-
meters for CKD patients. In the study by Lenz et al., 
the majority of doctors did not order anemia and 
screening tests for secondary hyperparathyroidism 
[49]. However, the questions did not evaluate the 
names of the clinical parameters in detail, so the 
answers may not reflect the accuracy of the scree-
ning tests being ordered. The screening for these 
complications of CKD should be initiated at Stage 
3 of CKD, and unless educational efforts should be 
aimed specifically at non-nephrologists to fill these 
knowledge gaps. 
The primary source of information on CKD for 
most doctors was textbooks, followed by online 
resources and CME seminars and medical journals 
falling back on the list. Recent data show that the-
re is an acute lack of awareness of clinical practice 
guidelines for CKD patients among primary provi-
ders [32]. Only some doctors routinely provide die-
tary counseling to patients with CKD, with 56% of 
house-officers, 67.1% of PG trainees and 70.8% of 
attending, and this is another area that needs im-
mediate attention. Doctors should be encouraged 
to read medical journals to stay abreast of latest 
research and trends in medical practice.
Regarding the overall results, junior doctors 
fared better probably due to the fact they have 
more knowledge of current guidelines, and they 
are more likely to comply with the current guideli-
nes, whereas the senior doctors are more likely to 
be established in their set patterns of practice. The 
KDOQI guidelines have undergone major changes 
in the last decade or so, and unless associate pro-
fessors and professors keep their knowledge up 
to date, their practice will also not be optimal. 
Educational efforts aimed at improving CKD care 
will have to be started for trainees and senior at-
tending alike. In order to succeed, guidelines will 
have to be presented in a manner that fosters 
reflection, critically appraises clinical evidence, is 
practice-based, and is easy to understand for prac-
titioners and patients alike [61]. Local and regional 
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workshops and seminars, teaching aids like posters 
and leaflets, and the local and national media can 
all be used to highlight the issues related to the 
management of CKD. The international guidelines 
should be disseminated to doctors [trainees and 
those in practice], and local guidelines developed 
for CKD patients in Pakistan.
This study has some limitations, the population 
of doctors was limited to three campuses of a pri-
vate teaching hospital, and the results may be ge-
neralizable to the larger set-up of public hospitals 
across the country. The study was conducted in a 
tertiary care hospital where patients pay a fee for 
consultation, which may affect attitudes towards 
early referral of patients. We cannot be certain that 
the answers truly reflect the knowledge of the per-
son completing the survey, given that the survey 
instrument was not formally validated in this res-
pect. However, we did receive a large number of 
responses from across the three campuses of our 
hospital, we believe that the data presented here 
are representative and cover important information 
about practice patterns of future providers. 
Conclusion
In conclusion, our survey results suggest that doc-
tors overall have significant knowledge gaps in CKD 
management, and these findings suggest that edu-
cational is needed to raise awareness of nephrology 
clinical practice guidelines and recommendations for 
CKD patients among our medical practitioners. This 
will have a significant impact on patient outcomes 
in a developing country with financial constraints, 
where the cost of care of end stage kidney patients 
is prohibitively expensive.
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